ChemoCentryx (NASDAQ:CCXI) Upgradedby SVBLeerinkLLC to Outperform

ChemoCentryx} stock has undergone multiple analysts rating changes in the recent past.  ChemoCentryx Upgradedby SVBLeerinkLLC on 10/11/2021. In a note to investors, the firm issued a new rating of Outperform. The analysts previously had rating of MarketPerform.

View More ChemoCentryx (NASDAQ:CCXI) Upgradedby SVBLeerinkLLC to Outperform